# Lansdowne Partners

> Lansdowne Partners is a VC fund in London backing Biotechnology and Finance. See 45 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 45
- Last investment: Jul 2026
- Lead investor: 20%
- Last fund: Jan 2017
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/lansdowne-partners
- Website: http://www.lansdownepartners.com

Lansdowne Partners is an alternative investment management firm that focused on equity portfolios. Founded in 1998, the company manages assets for a diversified institutional client base that includes some of the world’s largest and most sophisticated investors. Lansdowne Partners was founded in 1998 and is based in London, England.

## Contacts

5 contacts available for Lansdowne Partners. Shizune tracks 4 team members at Lansdowne Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/lansdowne-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $6.7M–$55M |
| Series B | $8.5M–$100M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 9 | 20% |
| Finance | 3 | 7% |
| Genetics | 3 | 7% |
| Health Care | 3 | 7% |
| Machine Learning | 3 | 7% |

59 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 10 | 22% |
| Series A | 8 | 18% |
| Series B | 7 | 16% |
| Series C | 6 | 13% |
| Seed | 3 | 7% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 20 | 44% |
| Austria | 3 | 7% |
| United States | 2 | 4% |
| Malta | 1 | 2% |
| France | 1 | 2% |

8 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Andrew Ryder | Chief Risk Officer | 0 | https://shizune.co/investors/profile/andrew-ryder |
| Hugh Orange | Partner, Chief Compliance Officer & Chief Financial Officer | 0 | https://shizune.co/investors/profile/hugh-orange |
| Paul Ruddock | Co-Founder and CEO | 0 | https://shizune.co/investors/profile/paul-ruddock-dc0a |
| Suzi Nutton | Partner & Chief Executive Officer | 0 | https://shizune.co/investors/profile/suzi-nutton |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MoA Technology | MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems. | $29.7M | Series C | Jul 23, 2026 |  |
| amnis | The simplest, fastest, and most affordable international payment platform for SMEs | $11.2M | Series B | Feb 26, 2025 |  |
| Nattergal | Nattergal operates as a nature restoration company. | $52M | Seed | Oct 16, 2024 |  |
| G.ST Antivirals | G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply. | $6.7M | Series A | Jan 25, 2024 |  |
| Oxford Quantum Circuits | Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies. | $100M | Series B | Nov 27, 2023 |  |
| TechMet | TechMet is a private industrial company that is building projects to secure the supply of the key metals critical to the future growth of EVs, Energy Storage and Renewable Energy. TechMet currently holds interests in both production and development assets in Africa, North America, and South America. |  |  | Aug 15, 2023 |  |
| TechMet | TechMet is a private industrial company that is building projects to secure the supply of the key metals critical to the future growth of EVs, Energy Storage and Renewable Energy. TechMet currently holds interests in both production and development assets in Africa, North America, and South America. | $200M |  | Aug 15, 2023 |  |
| Tungsten West | Tungsten West plc producing hemerdon mine. With demand for strategic metals, including tungsten and tin increasing rapidly, due to their heavy use in new technology, Tungsten West is concentrated on meeting this demand by restarting production at Hemerdon in the next 12 months at a low cost due to existing infrastructure. | $8.7M | Post-IPO Debt | May 19, 2023 |  |
| Oxford Ionics | Oxford Ionics is a quantum computing startup that provides innovations for the development of accurate and dependable quantum computers by combining high-performance qubits - trapped ions - with a noiseless electronic qubit control technology. Oxford Ionics' technology enables the manipulation of qubits with negligible noise and reliability,giving clients access to quantum computers that can control interconnected qubit registers in parallel and without sacrificing performance. | $36.6M | Series A | Jan 09, 2023 |  |
| Osler Diagnostics | Osler is a UK-based diagnostics company whose purpose is to enable anyone, anywhere, to access, understand, and act on their health, to live healthier, happier, and longer lives.Osler has developed the Osler Origin – a 'portable lab' that can provide lab-quality diagnostics to anyone, anywhere, at any time. The Osler Origin will offera wide portfolio of diagnostic tests and serve all major healthcare settings, globally. Osler was formed out of the University of Oxford in 2017, following decades of research from the same department that invented the portable electrochemical blood glucose sensor. The Company is headquartered in Oxford, UK. | $85M | Series C | Nov 07, 2022 |  |

10 of 45 investments shown.

## Co-investors
- [IP Group](https://shizune.co/investors/profile/ip-group-plc) — VC Fund, 9 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 9 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-science-enterprises) — VC Fund, 8 deals together
- [Invesco](https://shizune.co/investors/profile/invesco-perpetual) — VC Fund, 6 deals together
- [Woodford Investment Management](https://shizune.co/investors/profile/woodford-investment-management) — VC Fund, 6 deals together
- [Mercuria](https://shizune.co/investors/profile/mercuria-energy-group) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [Speedinvest](https://shizune.co/investors/profile/speedinvest) — VC Fund
- [tecnet equity](https://shizune.co/investors/profile/tecnet-equity) — VC Fund
- [aws Gründungsfonds](https://shizune.co/investors/profile/aws-grnderfonds) — VC Fund

## Featured in investor lists
- [All VC Funds in Austria](https://shizune.co/investors/vc-funds-austria)
- [Biotechnology VC Funds in Austria](https://shizune.co/investors/biotechnology-vc-funds-austria)
- [Biotech VC Funds in Austria](https://shizune.co/investors/biotech-vc-funds-austria)
- [All Investors in Austria](https://shizune.co/investors/investors-austria)
- [Biotech Investors in Austria](https://shizune.co/investors/biotech-investors-austria)
- [Financial Services Investors in Austria](https://shizune.co/investors/financial-services-investors-austria)

## FAQ

### What does Lansdowne Partners invest in?

Lansdowne Partners invests primarily in Biotechnology, Finance and Genetics startups, most often at Funding Round and Series A stage. Most of the 45 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Lansdowne Partners's check size?

Lansdowne Partners typically joins rounds of $6.7M–$55M at Series A and $8.5M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Lansdowne Partners participates in.

### How do I contact Lansdowne Partners?

Public channels for Lansdowne Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Lansdowne Partners?

The team at Lansdowne Partners includes Andrew Ryder (Chief Risk Officer), Hugh Orange (Partner, Chief Compliance Officer & Chief Financial Officer) and Paul Ruddock (Co-Founder and CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co